<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>

    <title>
                    Neurology |
                            Media Room |
                        Newswire
            </title>
    <link>https://co.newswire.com/</link>
    <description>Latest news from Newswire</description>

    <atom:link href="https://www.newswire.com/newsroom/rss/medicine-and-healthcare-neurology"
        rel="self" type="application/rss+xml" />

                                    <item>
        <title>BrainAMP Review 2025: Advanced BioNutritionals Memory &amp; Focus Supplement</title>
                    <link>https://www.newswire.com/news/brainamp-review-2025-advanced-bionutritionals-memory-focus-supplement-22628001</link>
            <guid>https://www.newswire.com/news/brainamp-review-2025-advanced-bionutritionals-memory-focus-supplement-22628001</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;A doctor‑developed nootropic formula that supports focus, mental clarity, memory recall and cognitive performance with clinically tested ingredients.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 20 Aug 2025 16:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Tony Crescenzo, CEO of Intelligent Waves (IW), Showcases PeakNeuro(TM), an AI-Driven Innovation for Human Performance, at Columbia University’s Teachers College Elite Summit.</title>
                    <link>https://www.newswire.com/news/tony-crescenzo-ceo-of-intelligent-waves-iw-showcases-peakneuro-tm-an-22579071</link>
            <guid>https://www.newswire.com/news/tony-crescenzo-ceo-of-intelligent-waves-iw-showcases-peakneuro-tm-an-22579071</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Intelligent Waves&#039; (IW) latest innovation in Human Performance Solutions, PeakNeuro&amp;trade;, is an AI-powered tool that uses audio neural entrainment to enhance cognitive function, improve sleep quality, accelerate learning, and sharpen focus. Crescenzo&#039;s presentation emphasized how this technology can help individuals recover from setbacks and rebuild stronger cognitive abilities, which are crucial for sustained growth in increasingly demanding life circumstances.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 22 May 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>InTheZone Labs Accelerates Growth Strategies, Builds Momentum With Positive User Feedback</title>
                    <link>https://www.newswire.com/news/inthezone-labs-accelerates-growth-strategies-builds-momentum-with-22525250</link>
            <guid>https://www.newswire.com/news/inthezone-labs-accelerates-growth-strategies-builds-momentum-with-22525250</guid>
                <description></description>
        <pubDate>Tue, 25 Feb 2025 14:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Veterinary Brain Surgery at the Veterinary Referral Center of Central Oregon Delivers Exceptional Results</title>
                    <link>https://www.newswire.com/news/veterinary-brain-surgery-at-the-veterinary-referral-center-of-central-22492728</link>
            <guid>https://www.newswire.com/news/veterinary-brain-surgery-at-the-veterinary-referral-center-of-central-22492728</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Complex veterinary procedure restores health and qualify of life, offering new hope to pet-parents facing complicated neurological disorders&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 14 Jan 2025 18:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Nitches Inc. Updates Shareholders on Amazon Store Launch and Online Sales Growth for InTheZone Labs Products</title>
                    <link>https://www.newswire.com/news/nitches-inc-updates-shareholders-on-amazon-store-launch-and-online-22485735</link>
            <guid>https://www.newswire.com/news/nitches-inc-updates-shareholders-on-amazon-store-launch-and-online-22485735</guid>
                <description></description>
        <pubDate>Thu, 12 Dec 2024 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Siegel Rare Neuroimmune Association Hosts 2024RNDS</title>
                    <link>https://www.newswire.com/news/siegel-rare-neuroimmune-association-hosts-2024rnds-22461519</link>
            <guid>https://www.newswire.com/news/siegel-rare-neuroimmune-association-hosts-2024rnds-22461519</guid>
                <description>&lt;p&gt;&lt;i&gt;Educational conference focused on diagnosis, research and treatment of rare neuroimmune disorders&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 12 Nov 2024 15:00:05 +0000</pubDate>
    </item>
                                                <item>
        <title>GB Sciences Signs Licensing Deal With EndoPure Life Sciences for 5% Gross Sales Royalty &amp; Sponsorship of First-in-Human Trial for Their Cannabinoid-Based Parkinson’s Drug</title>
                    <link>https://www.newswire.com/news/gb-sciences-signs-licensing-deal-with-endopure-life-sciences-for-5-22442507</link>
            <guid>https://www.newswire.com/news/gb-sciences-signs-licensing-deal-with-endopure-life-sciences-for-5-22442507</guid>
                <description>As a part of their Exclusive Licensing Deal, EndoPure Life Sciences will finance and sponsor first-in-human clinical trials, which help to advance GB Sciences’ cannabinoid-based products globally.</description>
        <pubDate>Tue, 15 Oct 2024 11:00:05 +0000</pubDate>
    </item>
                                                <item>
        <title>Mentavi Health Partners with NEI to Elevate Clinician Training and Expertise</title>
                    <link>https://www.newswire.com/news/mentavi-health-partners-with-nei-to-elevate-clinician-training-and-22419299</link>
            <guid>https://www.newswire.com/news/mentavi-health-partners-with-nei-to-elevate-clinician-training-and-22419299</guid>
                <description></description>
        <pubDate>Thu, 05 Sep 2024 13:35:13 +0000</pubDate>
    </item>
                                                <item>
        <title>The Siegel Rare Neuroimmune Association Kicks Off Awareness Campaign</title>
                    <link>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-kicks-off-awareness-campaign-22394962</link>
            <guid>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-kicks-off-awareness-campaign-22394962</guid>
                <description>Campaign launched on the date organization president’s wife developed symptoms of transverse myelitis</description>
        <pubDate>Wed, 31 Jul 2024 18:00:03 +0000</pubDate>
    </item>
                                                <item>
        <title>GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences</title>
                    <link>https://www.newswire.com/news/gb-sciences-signs-letter-of-intent-for-a-license-to-develop-and-market-22376008</link>
            <guid>https://www.newswire.com/news/gb-sciences-signs-letter-of-intent-for-a-license-to-develop-and-market-22376008</guid>
                <description>GB Sciences’ Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences’ Cannabinoid-based Treatments for a Suite of Neurological Disorders</description>
        <pubDate>Tue, 02 Jul 2024 13:00:05 +0000</pubDate>
    </item>
                                                <item>
        <title>The Siegel Rare Neuroimmune Association Creates First-Ever Online Micro-Course for People With Rare Neuroimmune Disorders</title>
                    <link>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-creates-first-ever-online-22366755</link>
            <guid>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-creates-first-ever-online-22366755</guid>
                <description>The online learning program reflects organization’s dedication to empowering individuals and families affected by these conditions with knowledge and support</description>
        <pubDate>Thu, 20 Jun 2024 13:30:04 +0000</pubDate>
    </item>
                                                <item>
        <title>Neuroscience and Quantum Researcher Ali Karakus Aims to Slow Aging of Brain and Facial Cells Using Principles of Quantum Entanglement and Space-Time Dilation</title>
                    <link>https://www.newswire.com/news/neuroscience-and-quantum-researcher-ali-karakus-aims-to-slow-aging-of-22338843</link>
            <guid>https://www.newswire.com/news/neuroscience-and-quantum-researcher-ali-karakus-aims-to-slow-aging-of-22338843</guid>
                <description>Ali Karakus&#039; Innovative Project Aims to Slow Aging of Brain and Facial Cells, Leading to the Foundation of a Private Deep Tech Institute in Istanbul</description>
        <pubDate>Sat, 25 May 2024 13:00:02 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto Announces Expert Jury for Its EEG Clinical Trial Sponsorship Program</title>
                    <link>https://www.newswire.com/news/zeto-announces-expert-jury-for-its-eeg-clinical-trial-sponsorship-22325251</link>
            <guid>https://www.newswire.com/news/zeto-announces-expert-jury-for-its-eeg-clinical-trial-sponsorship-22325251</guid>
                <description>The selected clinical research projects will be publicly announced by June 10th, 2024</description>
        <pubDate>Tue, 07 May 2024 16:00:12 +0000</pubDate>
    </item>
                                                <item>
        <title>All-In Nutritionals and Autism Today’s CEOs Create Joint Company, Neuro Nutritionals, to Support Autism and Neurodiverse Community</title>
                    <link>https://www.newswire.com/news/all-in-nutritionals-and-autism-todays-ceos-create-joint-company-neuro-22265828</link>
            <guid>https://www.newswire.com/news/all-in-nutritionals-and-autism-todays-ceos-create-joint-company-neuro-22265828</guid>
                <description>Lindsey Duncan, CN, ND, and founder of All-In Nutritionals, joins forces with Karen Simmons, founder and CEO of Autism Today, to co-found Neuro Nutritionals, LLC, a new company dedicated to providing targeted solutions, education, and supplements that support individuals on the spectrum.</description>
        <pubDate>Wed, 13 Mar 2024 14:00:01 +0000</pubDate>
    </item>
                                                <item>
        <title>The Siegel Rare Neuroimmune Association Marks 30 Years of Improving Quality of Life for People With Rare Neuroimmune Disorders</title>
                    <link>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-marks-30-years-of-improving-22253481</link>
            <guid>https://www.newswire.com/news/the-siegel-rare-neuroimmune-association-marks-30-years-of-improving-22253481</guid>
                <description>Not-for-profit celebrates past achievements and looks to the future</description>
        <pubDate>Thu, 29 Feb 2024 16:00:03 +0000</pubDate>
    </item>
                                                <item>
        <title>Fortifeye Vitamins Unveils Groundbreaking Eye Pressure and Neuro Cognitive Support Supplement</title>
                    <link>https://www.newswire.com/news/fortifeye-vitamins-unveils-groundbreaking-eye-pressure-and-neuro-22253323</link>
            <guid>https://www.newswire.com/news/fortifeye-vitamins-unveils-groundbreaking-eye-pressure-and-neuro-22253323</guid>
                <description>Revolutionary Supplement for Optimal Eye Health and Cognitive Function Enhancement</description>
        <pubDate>Wed, 28 Feb 2024 14:00:04 +0000</pubDate>
    </item>
                                                <item>
        <title>WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial</title>
                    <link>https://www.newswire.com/news/wallabyphenox-boldly-sets-new-benchmark-in-evidence-based-medicine-22233881</link>
            <guid>https://www.newswire.com/news/wallabyphenox-boldly-sets-new-benchmark-in-evidence-based-medicine-22233881</guid>
                <description>PROST Stroke Trial Results Published in JAMA Neurology</description>
        <pubDate>Mon, 05 Feb 2024 13:00:04 +0000</pubDate>
    </item>
                                                <item>
        <title>Mentavi Health Partnering with Colleges, Universities to Help Students with Mental Health Services  </title>
                    <link>https://www.newswire.com/news/mentavi-health-partnering-with-colleges-universities-to-help-students-22215384</link>
            <guid>https://www.newswire.com/news/mentavi-health-partnering-with-colleges-universities-to-help-students-22215384</guid>
                <description>The leader in mental health assessments is helping institutions that have limited resources and are outsourcing mental health assessments for ADHD, anxiety and depression to off-campus providers.</description>
        <pubDate>Tue, 09 Jan 2024 16:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO</title>
                    <link>https://www.newswire.com/news/cmta-appoints-biotech-industry-veteran-suzanne-bruhn-phd-as-new-ceo-22163841</link>
            <guid>https://www.newswire.com/news/cmta-appoints-biotech-industry-veteran-suzanne-bruhn-phd-as-new-ceo-22163841</guid>
                <description></description>
        <pubDate>Mon, 06 Nov 2023 14:15:22 +0000</pubDate>
    </item>
                                                <item>
        <title>Ischemix, Inc. Completes Successful Phase 1 Trial of Novel Compound to Treat Traumatic Brain Injury (TBI); Preparing for Conduct of Phase 2 Trial</title>
                    <link>https://www.newswire.com/news/ischemix-inc-completes-successful-phase-1-trial-of-novel-compound-to-22097048</link>
            <guid>https://www.newswire.com/news/ischemix-inc-completes-successful-phase-1-trial-of-novel-compound-to-22097048</guid>
                <description>CMX-2043, a novel, proprietary cytoprotective drug candidate, demonstrated excellent safety and tolerability in a Phase 1 single ascending and multiple ascending dose (SAD-MAD) clinical trial. CMX-2043 has previously demonstrated safety and efficacy in extensive preclinical pharmacology, toxicology and TBI translational studies. CMX-2043 will be Phase 2-ready by the first quarter of 2024.</description>
        <pubDate>Fri, 25 Aug 2023 19:35:05 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform</title>
                    <link>https://www.newswire.com/news/adhd-online-adds-social-media-addiction-assessment-to-its-online-22080471</link>
            <guid>https://www.newswire.com/news/adhd-online-adds-social-media-addiction-assessment-to-its-online-22080471</guid>
                <description>As Surgeon General advisory reports teens&#039; use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its efforts.</description>
        <pubDate>Tue, 11 Jul 2023 11:00:08 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Welcomes Dr. Barry Herman as Chief Medical Officer</title>
                    <link>https://www.newswire.com/news/adhd-online-welcomes-dr-barry-herman-as-chief-medical-officer-22057604</link>
            <guid>https://www.newswire.com/news/adhd-online-welcomes-dr-barry-herman-as-chief-medical-officer-22057604</guid>
                <description>The leading online ADHD treatment platform brings in Herman, who has more than two decades of managed care and pharmaceutical experience and is one of the leading experts in behavioral health.</description>
        <pubDate>Mon, 12 Jun 2023 13:00:57 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto Awarded &#039;Best New Neurology Solution&#039; in 2023 by MedTech Breakthrough Awards</title>
                    <link>https://www.newswire.com/news/zeto-awarded-best-new-neurology-solution-in-2023-by-medtech-22044027</link>
            <guid>https://www.newswire.com/news/zeto-awarded-best-new-neurology-solution-in-2023-by-medtech-22044027</guid>
                <description>Prestigious International Annual Awards Program Recognizes Standout Digital Health &amp; Medical Technology Products and Companies</description>
        <pubDate>Mon, 22 May 2023 13:00:16 +0000</pubDate>
    </item>
                                                <item>
        <title>Charcot-Marie-Tooth Association: Sperm Donor With CMT Gene Passes It on to Multiple Families</title>
                    <link>https://www.newswire.com/news/charcot-marie-tooth-association-sperm-donor-with-cmt-gene-passes-it-on-22029401</link>
            <guid>https://www.newswire.com/news/charcot-marie-tooth-association-sperm-donor-with-cmt-gene-passes-it-on-22029401</guid>
                <description></description>
        <pubDate>Tue, 09 May 2023 11:00:07 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Reports on Link Between ADHD and Body Dysmorphia</title>
                    <link>https://www.newswire.com/news/adhd-online-reports-on-link-between-adhd-and-body-dysmorphia-22020675</link>
            <guid>https://www.newswire.com/news/adhd-online-reports-on-link-between-adhd-and-body-dysmorphia-22020675</guid>
                <description>Online ADHD testing and assessment leader provides guidance for people managing symptoms of the disorders.</description>
        <pubDate>Wed, 26 Apr 2023 15:09:29 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Leaders Address Hidden Issue of Entrepreneurs&#039; Common Mental Health Challenges</title>
                    <link>https://www.newswire.com/news/adhd-online-leaders-address-hidden-issue-of-entrepreneurs-common-22008473</link>
            <guid>https://www.newswire.com/news/adhd-online-leaders-address-hidden-issue-of-entrepreneurs-common-22008473</guid>
                <description>CEO Zach Booker also praises Midwest as haven for startups</description>
        <pubDate>Mon, 17 Apr 2023 14:00:06 +0000</pubDate>
    </item>
                                                <item>
        <title>An Independent Study Comparing Blink Reflex Detection Device EyeStat to Standard Lab Techniques Concludes That the Device Provides Reliable and Accurate Measures</title>
                    <link>https://www.newswire.com/news/an-independent-study-comparing-blink-reflex-detection-device-eyestat-21976422</link>
            <guid>https://www.newswire.com/news/an-independent-study-comparing-blink-reflex-detection-device-eyestat-21976422</guid>
                <description>The research opens the doors for promising applications that can help people with neurological diseases such as Parkinson&#039;s.</description>
        <pubDate>Thu, 09 Mar 2023 15:00:10 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Executives Will Be Featured in Panels at SXSW</title>
                    <link>https://www.newswire.com/news/adhd-online-executives-will-be-featured-in-panels-at-sxsw-21975285</link>
            <guid>https://www.newswire.com/news/adhd-online-executives-will-be-featured-in-panels-at-sxsw-21975285</guid>
                <description>Leaders of online ADHD testing and assessment will discuss turning startups into long-term successes and what can be learned about mental health.</description>
        <pubDate>Mon, 06 Mar 2023 19:00:43 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Alerts People to Changes in Telehealth, Prescriptions as Public Health Emergency Ends</title>
                    <link>https://www.newswire.com/news/adhd-online-alerts-people-to-changes-in-telehealth-prescriptions-as-21964746</link>
            <guid>https://www.newswire.com/news/adhd-online-alerts-people-to-changes-in-telehealth-prescriptions-as-21964746</guid>
                <description>The industry&#039;s leader in ADHD assessment and treatment said telehealth will return to pre-pandemic rules when the Public Health Emergency expires on May 11.</description>
        <pubDate>Thu, 23 Feb 2023 18:00:12 +0000</pubDate>
    </item>
                                                <item>
        <title>The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023</title>
                    <link>https://www.newswire.com/news/the-dan-lewis-foundation-for-brain-regeneration-research-announces-21962110</link>
            <guid>https://www.newswire.com/news/the-dan-lewis-foundation-for-brain-regeneration-research-announces-21962110</guid>
                <description>The Dan Lewis Foundation for Brain Regeneration Research (the DLF) announces the 2023 DLF Prize.</description>
        <pubDate>Thu, 23 Feb 2023 16:00:10 +0000</pubDate>
    </item>
                                                <item>
        <title>Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board</title>
                    <link>https://www.newswire.com/news/neurocentria-announces-dr-thomas-s-dhof-to-join-the-scientific-21927610</link>
            <guid>https://www.newswire.com/news/neurocentria-announces-dr-thomas-s-dhof-to-join-the-scientific-21927610</guid>
                <description>The appointment further strengthens the company&#039;s scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria&#039;s approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders.</description>
        <pubDate>Fri, 13 Jan 2023 14:00:10 +0000</pubDate>
    </item>
                                                <item>
        <title>Over 20 Million Suffer From Peripheral Neuropathy, St. Pete Medical Group Aims to Help</title>
                    <link>https://www.newswire.com/news/over-20-million-suffer-from-peripheral-neuropathy-st-pete-medical-21902532</link>
            <guid>https://www.newswire.com/news/over-20-million-suffer-from-peripheral-neuropathy-st-pete-medical-21902532</guid>
                <description></description>
        <pubDate>Wed, 14 Dec 2022 17:30:03 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto Implements encevis&#039; Seizure Detection and Trending Algorithms</title>
                    <link>https://www.newswire.com/news/zeto-implements-encevis-seizure-detection-and-trending-algorithms-21890744</link>
            <guid>https://www.newswire.com/news/zeto-implements-encevis-seizure-detection-and-trending-algorithms-21890744</guid>
                <description>The only zero-prep, full-montage, rapid EEG solution for clinical use now offers near real-time notification of ongoing seizures by using reliable FDA cleared seizure detection software</description>
        <pubDate>Thu, 01 Dec 2022 13:00:09 +0000</pubDate>
    </item>
                                                <item>
        <title>SportGait Partners With the Carrick Institute, Incorporating Cutting-Edge Concussion Support and Recovery Technology</title>
                    <link>https://www.newswire.com/news/sportgait-partners-with-the-carrick-institute-incorporating-cutting-21859039</link>
            <guid>https://www.newswire.com/news/sportgait-partners-with-the-carrick-institute-incorporating-cutting-21859039</guid>
                <description></description>
        <pubDate>Wed, 26 Oct 2022 18:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>31 ADHD Stories in 31 Days with Award-Winning Journalist and TV/Radio Personality Lindsay Guentzel and ADHD Online</title>
                    <link>https://www.newswire.com/news/31-adhd-stories-in-31-days-with-award-winning-journalist-and-tv-radio-21852348</link>
            <guid>https://www.newswire.com/news/31-adhd-stories-in-31-days-with-award-winning-journalist-and-tv-radio-21852348</guid>
                <description>Guentzel and ADHD Online partner to publish a podcast episode every day during October, providing information and support while breaking down stigmas about ADHD and mental health.</description>
        <pubDate>Tue, 18 Oct 2022 18:00:08 +0000</pubDate>
    </item>
                                                <item>
        <title>ADHD Online Nominated for Business Award by Grand Rapids Chamber of Commerce</title>
                    <link>https://www.newswire.com/news/adhd-online-nominated-for-business-award-by-grand-rapids-chamber-of-21835266</link>
            <guid>https://www.newswire.com/news/adhd-online-nominated-for-business-award-by-grand-rapids-chamber-of-21835266</guid>
                <description>The industry leader in online ADHD assessments is a finalist for the Excellence in Business category.</description>
        <pubDate>Mon, 03 Oct 2022 13:00:06 +0000</pubDate>
    </item>
                                                <item>
        <title>ADM Diagnostics, Inc. Awarded $1.96 Million Grant From the National Institutes of Health</title>
                    <link>https://www.newswire.com/news/adm-diagnostics-inc-awarded-1-96-million-grant-from-the-national-21833401</link>
            <guid>https://www.newswire.com/news/adm-diagnostics-inc-awarded-1-96-million-grant-from-the-national-21833401</guid>
                <description>Project will use brain imaging and blood markers to detect the effects of Traumatic Brain Injury and distinguish them from Alzheimer&#039;s disease</description>
        <pubDate>Tue, 27 Sep 2022 13:00:15 +0000</pubDate>
    </item>
                                                <item>
        <title>Overwhelmed Mental Health Care Workers Demonstrate Need for New Ways to Provide Care</title>
                    <link>https://www.newswire.com/news/overwhelmed-mental-health-care-workers-demonstrate-need-for-new-ways-21812987</link>
            <guid>https://www.newswire.com/news/overwhelmed-mental-health-care-workers-demonstrate-need-for-new-ways-21812987</guid>
                <description>ADHD Online alleviates overburdened system&#039;s long wait times for patients to receive ADHD assessments, treatments, and care</description>
        <pubDate>Wed, 07 Sep 2022 13:00:08 +0000</pubDate>
    </item>
                                                <item>
        <title>Cortechs.ai Awarded Million Dollar NIH Grant for Early Diagnosis of Alzheimer&#039;s Disease Using Advanced Diffusion MRI Technique</title>
                    <link>https://www.newswire.com/news/cortechs-ai-awarded-million-dollar-nih-grant-for-early-diagnosis-of-21803616</link>
            <guid>https://www.newswire.com/news/cortechs-ai-awarded-million-dollar-nih-grant-for-early-diagnosis-of-21803616</guid>
                <description>The National Institute of Health awards Cortechs.ai a multimillion grant to quantify microstructural changes in Alzheimer&#039;s Disease using Restriction Spectrum Imaging.</description>
        <pubDate>Mon, 29 Aug 2022 15:00:04 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto and Next Gen Neuro Partner for Remote EEG Monitoring</title>
                    <link>https://www.newswire.com/news/zeto-and-next-gen-neuro-partner-for-remote-eeg-monitoring-21808344</link>
            <guid>https://www.newswire.com/news/zeto-and-next-gen-neuro-partner-for-remote-eeg-monitoring-21808344</guid>
                <description>Providing this end-to-end solution will make EEGs accessible to any healthcare facility in the US</description>
        <pubDate>Mon, 29 Aug 2022 13:00:10 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto Now Offers Remote Routine and Continuous EEG Monitoring Service to Its Customers for an Hourly Flat Rate</title>
                    <link>https://www.newswire.com/news/zeto-now-offers-remote-routine-and-continuous-eeg-monitoring-service-21786666</link>
            <guid>https://www.newswire.com/news/zeto-now-offers-remote-routine-and-continuous-eeg-monitoring-service-21786666</guid>
                <description>This service is available in real time upon request with a 30-minute notice 24/7/365.</description>
        <pubDate>Wed, 03 Aug 2022 13:00:14 +0000</pubDate>
    </item>
                                                <item>
        <title>neurocare group AG obtains patent grant on treatment method for neuromodulation in Japan</title>
                    <link>https://www.newswire.com/news/neurocare-group-ag-obtains-patent-grant-on-treatment-method-for-21748327</link>
            <guid>https://www.newswire.com/news/neurocare-group-ag-obtains-patent-grant-on-treatment-method-for-21748327</guid>
                <description></description>
        <pubDate>Thu, 23 Jun 2022 15:00:05 +0000</pubDate>
    </item>
                                                <item>
        <title>Cortechs.ai Appoints New Chief Financial Officer</title>
                    <link>https://www.newswire.com/news/cortechs-ai-appoints-new-chief-financial-officer-21734912</link>
            <guid>https://www.newswire.com/news/cortechs-ai-appoints-new-chief-financial-officer-21734912</guid>
                <description>Accomplished Former GE Chief Financial Officer Michi Sassa Joins Company</description>
        <pubDate>Tue, 14 Jun 2022 15:00:07 +0000</pubDate>
    </item>
                                                <item>
        <title>neurocare group AG continues expansion with opening of first UK clinic in London</title>
                    <link>https://www.newswire.com/news/neurocare-group-ag-continues-expansion-with-opening-of-first-uk-clinic-21740079</link>
            <guid>https://www.newswire.com/news/neurocare-group-ag-continues-expansion-with-opening-of-first-uk-clinic-21740079</guid>
                <description></description>
        <pubDate>Tue, 14 Jun 2022 14:00:15 +0000</pubDate>
    </item>
                                                <item>
        <title>neurocare group AG Announces Recent Start of a Phase III Trial Examining the Cost-Effectiveness of TMS for Patients With Exposure Therapy-Resistant OCD</title>
                    <link>https://www.newswire.com/news/neurocare-group-ag-announces-recent-start-of-a-phase-iii-trial-21734542</link>
            <guid>https://www.newswire.com/news/neurocare-group-ag-announces-recent-start-of-a-phase-iii-trial-21734542</guid>
                <description></description>
        <pubDate>Wed, 08 Jun 2022 15:00:08 +0000</pubDate>
    </item>
                                                <item>
        <title>ALLM announced as Get With The Guidelines® Compatible Vendor</title>
                    <link>https://www.newswire.com/news/allm-announced-as-get-with-the-guidelines-compatible-vendor-21730256</link>
            <guid>https://www.newswire.com/news/allm-announced-as-get-with-the-guidelines-compatible-vendor-21730256</guid>
                <description></description>
        <pubDate>Mon, 06 Jun 2022 13:00:13 +0000</pubDate>
    </item>
                                                <item>
        <title>Zeto Introduces a Remote EEG Reading Service to Its Customers</title>
                    <link>https://www.newswire.com/news/zeto-introduces-a-remote-eeg-reading-service-to-its-customers-21723108</link>
            <guid>https://www.newswire.com/news/zeto-introduces-a-remote-eeg-reading-service-to-its-customers-21723108</guid>
                <description></description>
        <pubDate>Thu, 26 May 2022 15:11:30 +0000</pubDate>
    </item>
                                                <item>
        <title>neurocare Announces Entry Into Ketamine-Assisted Therapy Market Through Cooperation With Privatpraxis Dr. Scheib in Berlin</title>
                    <link>https://www.newswire.com/news/neurocare-announces-entry-into-ketamine-assisted-therapy-market-21707976</link>
            <guid>https://www.newswire.com/news/neurocare-announces-entry-into-ketamine-assisted-therapy-market-21707976</guid>
                <description></description>
        <pubDate>Wed, 11 May 2022 07:00:05 +0000</pubDate>
    </item>
                                                <item>
        <title>neurocare group AG announces Publication in Biological Psychiatry CNNI Revealing the First Clinically Actionable EEG Biomarker in ADHD</title>
                    <link>https://www.newswire.com/news/neurocare-group-ag-announces-publication-in-biological-psychiatry-cnni-21702952</link>
            <guid>https://www.newswire.com/news/neurocare-group-ag-announces-publication-in-biological-psychiatry-cnni-21702952</guid>
                <description></description>
        <pubDate>Fri, 06 May 2022 11:22:32 +0000</pubDate>
    </item>
                                                <item>
        <title>Dr. Mohana Rao Patibandla, a 2022 ThreeBestRated® Award-Winning Neurosurgeon in Guntur, Andhra Pradesh, Shares Simple Self-Care Practices for Epilepsy Patients</title>
                    <link>https://www.newswire.com/news/dr-mohana-rao-patibandla-a-2022-threebestrated-award-winning-21690806</link>
            <guid>https://www.newswire.com/news/dr-mohana-rao-patibandla-a-2022-threebestrated-award-winning-21690806</guid>
                <description></description>
        <pubDate>Fri, 22 Apr 2022 14:00:06 +0000</pubDate>
    </item>
                        
</channel>
</rss>
